English | Español

Regulatory
+ Regulatory
Patient Daily | May 13, 2026

Pacific Research Institute President on 340B program: 'Patients don't see the savings. Hospitals pocket the profits'
+ Regulatory
Patient Daily | May 11, 2026

HEAL Network Director Parente on 340B program: 'Patients often see none of the discount'
+ Regulatory
Patient Daily | May 6, 2026

Attorney General Jackson on PBMs: 'Just three companies manage roughly 80% of prescription claims in the U.S.'
+ Regulatory
Patient Daily | May 4, 2026

Community Oncology Alliance Exec. Director on PBMs: 'The top PBMs are the scourge of society'
+ Regulatory
Patient Daily | Apr 29, 2026

PhRMA questions hospital use of 340B revenues after Minnesota reporting data shows $1.3B in earnings
+ Regulatory
Patient Daily | Apr 29, 2026

USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'
+ Regulatory
Patient Daily | Apr 28, 2026

Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
+ Regulatory
Patient Daily | Apr 24, 2026

Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes